What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Dopamine
- Neurotransmitter
Francisco Silveira Guimarães spends much of his time researching Cannabidiol, Pharmacology, Anxiolytic, Internal medicine and Endocrinology.
His study in Cannabidiol is interdisciplinary in nature, drawing from both Anxiety, Schizophrenia, Cannabinoid and Cannabinoid receptor.
His Pharmacology research includes elements of Haloperidol, Catalepsy, Endocannabinoid system and Psychotomimetic.
Francisco Silveira Guimarães interconnects Neurogenesis and Neuroscience in the investigation of issues within Endocannabinoid system.
The concepts of his Anxiolytic study are interwoven with issues in Elevated plus maze and Diazepam.
His work on Hippocampal formation as part of general Endocrinology research is frequently linked to EZH2, DNA methyltransferase and DNA methylation, thereby connecting diverse disciplines of science.
His most cited work include:
- Role of 5-HT in stress, anxiety, and depression (794 citations)
- Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. (316 citations)
- Antianxiety effect of cannabidiol in the elevated plus-maze (221 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Internal medicine, Endocrinology, Neuroscience, Pharmacology and Cannabidiol.
His Endocrinology research includes themes of Elevated plus maze and Serotonin.
The Neuroscience study which covers Neurotransmission that intersects with Mean arterial pressure.
His Pharmacology research is multidisciplinary, relying on both Anesthesia, Receptor, Anxiolytic, Haloperidol and 5-HT receptor.
Francisco Silveira Guimarães has researched Cannabidiol in several fields, including Clozapine, Antipsychotic, Schizophrenia, Cannabinoid and Receptor antagonist.
His Cannabinoid research is multidisciplinary, incorporating perspectives in Endocannabinoid system and Cannabinoid receptor.
He most often published in these fields:
- Internal medicine (34.04%)
- Endocrinology (33.33%)
- Neuroscience (29.79%)
What were the highlights of his more recent work (between 2011-2019)?
- Cannabidiol (28.37%)
- Internal medicine (34.04%)
- Endocrinology (33.33%)
In recent papers he was focusing on the following fields of study:
His scientific interests lie mostly in Cannabidiol, Internal medicine, Endocrinology, Pharmacology and Neuroscience.
Francisco Silveira Guimarães has included themes like Anesthesia, Memory consolidation, Psychosis, Neuroprotection and Serotonin in his Cannabidiol study.
In the field of Internal medicine, his study on Nitric oxide, Hippocampus, Antagonist and Stria terminalis overlaps with subjects such as Periaqueductal gray.
His work in the fields of Endocrinology, such as Striatum, overlaps with other areas such as Neuroinflammation.
His Pharmacology study combines topics in areas such as Fluoxetine and Anxiolytic.
His Neuroscience research focuses on subjects like Endocannabinoid system, which are linked to Cannabinoid, AM251, Agonist and Neurogenesis.
Between 2011 and 2019, his most popular works were:
- Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders (216 citations)
- Animal models of anxiety disorders and stress (180 citations)
- Cannabidiol, neuroprotection and neuropsychiatric disorders. (145 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Dopamine
- Neurotransmitter
His main research concerns Cannabidiol, Pharmacology, Neuroscience, Cannabinoid and Endocannabinoid system.
The Cannabidiol study combines topics in areas such as Anesthesia, Psychosis, Internal medicine and Endocrinology.
His Endocrinology study incorporates themes from Conditioned emotional response and Neurotransmission.
Many of his studies on Pharmacology apply to Anxiogenic as well.
His studies link Cannabinoid receptor with Neuroscience.
His Endocannabinoid system study combines topics from a wide range of disciplines, such as Neurogenesis and AM251.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
